Jonathan R. Strosberg, MD of the H. Lee Moffitt Cancer Center discusses a poster he is presenting at ASCO GI 2017 about the Significant Improvement in Quality of Life from the data of the NETTER-1 Phase III trial.
NETTER-1 Significant Improvement in Quality of Life
